These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11078190)

  • 1. Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.
    Moe ST; Smith DL; DelMar EG; Shimizu SM; Van Wagenen BC; Balandrin MF; Chien YE; Raszkiewicz JL; Artman LD; White HS; Mueller AL
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2411-5. PubMed ID: 11078190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist.
    Moe ST; Shimizu SM; Smith DL; Van Wagenen BC; DelMar EG; Balandrin MF; Chien Y; Raszkiewicz JL; Artman LD; Mueller AL; Lobkovsky E; Clardy J
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1915-20. PubMed ID: 10450953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a series of γ-amino alcohols comprising an N-methyl isoindoline moiety and their evaluation as NMDA receptor antagonists.
    Müller A; Höfner G; Renukappa-Gutke T; Parsons CG; Wanner KT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5795-9. PubMed ID: 21875803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity.
    Jimonet P; Ribeill Y; Bohme GA; Boireau A; Chevé M; Damour D; Doble A; Genevois-Borella A; Herman F; Imperato A; Le Guern S; Manfré F; Pratt J; Randle JC; Stutzmann JM; Mignani S
    J Med Chem; 2000 Jun; 43(12):2371-81. PubMed ID: 10882363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
    Conti P; Pinto A; Tamborini L; Madsen U; Nielsen B; Bräuner-Osborne H; Hansen KB; Landucci E; Pellegrini-Giampietro DE; De Sarro G; Donato Di Paola E; De Micheli C
    ChemMedChem; 2010 Sep; 5(9):1465-75. PubMed ID: 20665761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant activity and cerebral protection of chronic lithium chloride via NMDA receptor/nitric oxide and phospho-ERK.
    Mohammad Jafari R; Ghahremani MH; Rahimi N; Shadboorestan A; Rashidian A; Esmaeili J; Ejtemaei Mehr S; Dehpour AR
    Brain Res Bull; 2018 Mar; 137():1-9. PubMed ID: 29102713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
    Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
    J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines.
    Sun S; Wallach J; Adejare A
    Med Chem; 2014; 10(8):843-52. PubMed ID: 24773376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.
    Folbergrová J
    Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC), a new class of NMDA-receptor antagonist: molecular design by a novel conformational restriction strategy.
    Shuto S; Yoshii K; Matsuda A
    Jpn J Pharmacol; 2001 Mar; 85(3):207-13. PubMed ID: 11325012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, chiral resolution, and enantiopharmacology of a potent 2,3-benzodiazepine derivative as noncompetitive AMPA receptor antagonist.
    Zappalà M; Postorino G; Micale N; Caccamese S; Parrinello N; Grazioso G; Roda G; Menniti FS; De Sarro G; Grasso S
    J Med Chem; 2006 Jan; 49(2):575-81. PubMed ID: 16420043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.